Liver fat content in type 2 diabetes: Relationship with hepatic perfusion and substrate metabolism

Diabetes

Volumn 59, Issue 11, 2010, Pages 2747-2754

  Rijzewijk, Luuk J ^a   Van Der Meer, Rutger W ^b   Lubberink, Mark ^a   Lamb, Hildo J ^b   Romijn, Johannes A ^b   De Roos, Albert ^b   Twisk, Jos W ^a   Heine, Robert J ^a,c   Lammertsma, Adriaan A ^a   Smit, Johannes W A ^b   Diamant, Michaela ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; FLUORODEOXYGLUCOSE F 18; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OXYGEN 15; PALMITIC ACID C 11; TRIACYLGLYCEROL;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FATTY ACID METABOLISM; FATTY LIVER; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HIGH RISK PATIENT; HUMAN; INSULIN INFUSION; LIVER METABOLISM; LIVER PARENCHYMA; LIVER PERFUSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STATISTICAL SIGNIFICANCE; TISSUE PERFUSION;

AGE OF ONSET; BLOOD VOLUME; BODY MASS INDEX; BODY SURFACE AREA; DIABETES MELLITUS, TYPE 2; DIETARY FATS; FATTY ACIDS; FATTY LIVER; FLUORODEOXYGLUCOSE F18; HEPATIC ARTERY; HUMANS; KINETICS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERFUSION; PORTAL VEIN; POSITRON-EMISSION TOMOGRAPHY; REFERENCE VALUES; TRIGLYCERIDES;

EID: 78049238673     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db09-1201     Document Type: Article

References (52)

1. James WP. The epidemiology of obesity: the size of the problem. J Intern Med 2008;263:336-352
2. Kotronen A, Yki-Järvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28:27-38
3. Lautamäki R, Borra R, Iozzo P, Komu M, Lehtimäki T, Salmi M, Jalkanen S, Airaksinen KE, Knuuti J, Parkkola R, Nuutila P. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 2006;291:E282-E290 (Pubitemid 44035287)
4. Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 2003;46:733-749
5. Hwang JH, Stein DT, Barzilai N, Cui MH, Tonelli J, Kishore P, Hawkins M. Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am J Physiol Endocrinol Metab 2007;293:E1663-E1669
6. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-1812
7. Leclercq IA, Da Silva Morais A, Schroyen B, Van Hul N, Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J Hepatol 2007;47:142-156
8. Postic C, Dentin R, Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabete Metab 2004;30:398-408 (Pubitemid 39648006)
9. Nguyen P, Leray V, Diez M, Serisier S, Le BJ, Siliart B, Dumon H. Liver lipid metabolism. J Anim Physiol Anim Nutr (Berl) 2008;92:272-283
10. Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, Halavaara J, Yki-Järvinen H. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002;87:3023-3028 (Pubitemid 34816338)
11. Kotronen A, Vehkavaara S, Seppälä-Lindroos A, Bergholm R, Yki-Järvinen H. Effect of liver fat on insulin clearance. Am J Physiol Endocrinol Metab 2007;293:E1709-E1715
12. DeFronzo RA, Gunnarsson R, Björkman O, Olsson M, Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 1985;76:149-155 (Pubitemid 15240430)
13. Sidossis LS, Mittendorfer B, Walser E, Chinkes D, Wolfe RR. Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion. Am J Physiol 1998;275:E798-E805
14. Wahren J, Sato Y, Ostman J, Hagenfeldt L, Felig P. Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise. J Clin Invest 1984;73:1367-1376 (Pubitemid 14139532)
15. Waldhäusl WK, Gasić S, Bratusch-Marrain P, Nowotny P. The 75-g oral glucose tolerance test: effect on splanchnic metabolism of substrates and pancreatic hormone release in healthy man. Diabetologia 1983;25:489-495 (Pubitemid 14200885)
16. Iozzo P, Jarvisalo MJ, Kiss J, Borra R, Naum GA, Viljanen A, Viljanen T, Gastaldelli A, Buzzigoli E, Guiducci L, Barsotti E, Savunen T, Knuuti J, Haaparanta-Solin M, Ferrannini E, Nuutila P. Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs. Gastroenterology 2007;132:531-542
17. 18F]fluoro-6-thia-heptadecanoic acid and PET. Eur J Nucl Med Mol Imaging 2003;30:1160-1164
18. Iozzo P, Geisler F, Oikonen V, Mäki M, Takala T, Solin O, Ferrannini E, Knuuti J, Nuutila P. 18F-FDG PET Study: Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET Study. J Nucl Med 2003;44:682-689 (Pubitemid 39655201)
19. Iozzo P, Turpeinen AK, Takala T, Oikonen V, Bergman J, Grönroos T, Ferrannini E, Nuutila P, Knuuti J. Defective liver disposal of free fatty acids in patients with impaired glucose tolerance. J Clin Endocrinol Metab 2004;89:3496-3502 (Pubitemid 38951926)
20. Iozzo P, Hallsten K, Oikonen V, Virtanen KA, Kemppainen J, Solin O, Ferrannini E, Knuuti J, Nuutila P. Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control. J Clin Endocrinol Metab 2003;88:2055-2060 (Pubitemid 36549877)
21. Iozzo P, Lautamaki R, Geisler F, Virtanen KA, Oikonen V, Haaparanta M, Yki-Jarvinen H, Ferrannini E, Knuuti J, Nuutila P. Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver. Diabetologia 2004;47:1149-1156 (Pubitemid 39093311)
22. Balci A, Karazincir S, Sumbas H, Oter Y, Egilmez E, Inandi T. Effects of diffuse fatty infiltration of the liver on portal vein flow hemodynamics. J Clin Ultrasound 2008;36:134-140
23. Erdogmus B, Tamer A, Buyukkaya R, Yazici B, Buyukkaya A, Korkut E, Alcelik A, Korkmaz U. Portal vein hemodynamics in patients with non-alcoholic fatty liver disease. Tohoku J Exp Med 2008;215:89-93
24. Seifalian AM, Chidambaram V, Rolles K, Davidson BR. In vivo demonstration of impaired microcirculation in steatotic human liver grafts. Liver Transpl Surg 1998;4:71-77
25. Seifalian AM, Piasecki C, Agarwal A, Davidson BR. The effect of graded steatosis on flow in the hepatic parenchymal microcirculation. Transplantation 1999;68:780-784
26. Taniguchi H, Oguro A, Koyama H, Masuyama M, Takahashi T. Analysis of models for quantification of arterial and portal blood flow in the human liver using PET. J Comput Assist Tomogr 1996;20:135-144 (Pubitemid 26044043)
27. 15O PET images using tissue-derived arterial and portal input functions. Eur J Nucl Med Mol Imaging 2008;35: 1899-1911
28. 2O-PET and its relationship with glucose metabolism and substrate levels. J Hepatol 2008;48:974-982
29. van der Meer RW, Rijzewijk LJ, de Jong HW, Lamb HJ, Lubberink M, Romijn JA, Bax JJ, de Roos A, Kamp O, Paulus WJ, Heine RJ, Lammertsma AA, Smit JW, Diamant M. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus. Circulation 2009;119:2069-2077
30. van der Meer RW, Hammer S, Lamb HJ, Frölich M, Diamant M, Rijzewijk LJ, de Roos A, Romijn JA, Smit JW. Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men. J Clin Endocrinol Metab 2008;93:2702-2708 (Pubitemid 352008539)
31. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, Graveron-Demilly D. Java-based graphical user interface for the MRUI quantitation package. MAGMA 2001;12:141-152 (Pubitemid 32510133)
32. Elbers JM, Haumann G, Asscheman H, Seidell JC, Gooren LJ. Reproducibility of fat area measurements in young, non-obese subjects by computerized analysis of magnetic resonance images. Int J Obes Relat Metab Disord 1997;21:1121-1129 (Pubitemid 27511486)
33. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223
34. Herrero P, Peterson LR, McGill JB, Matthew S, Lesniak D, Dence C, Gropler RJ. Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus. J Am Coll Cardiol 2006;47:598-604
35. 11C]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemia. Nucl Med Biol 2006;33:521-528
36. Cunningham VJ, Jones T. Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab 1993;13:15-23
37. van de Kerkhof J, Schalkwijk CG, Konings CJ, Cheriex EC, van der Sande FM, Scheffer PG, ter Wee PM, Leunissen KM, Kooman JP. Nepsilon-(carboxymethyl) lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients. Nephrol Dial Transplant 2004;19:910-916
38. Johnson DJ, Muhlbacher F, Wilmore DW. Measurement of hepatic blood flow. J Surg Res 1985;39:470-481
39. Sun CK, Zhang XY, Zimmermann A, Davis G, Wheatley AM. Effect of ischemia-reperfusion injury on the microcirculation of the steatotic liver of the Zucker rat. Transplantation 2001;72:1625-1631
40. Sato N, Eguchi H, Inoue A, Matsumura T, Kawano S, Kamada T. Hepatic microcirculation in Zucker fatty rats. Adv Exp Med Biol 1986;200:477-483
41. Teramoto K, Bowers JL, Kruskal JB, Clouse ME. Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat. Transplantation 1993;56:1076-1082
42. McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatology 2004;40:386-393
43. Sun CK, Zhang XY, Wheatley AM. Increased NAD(P)H fluorescence with decreased blood flow in the steatotic liver of the obese Zucker rat. Microvasc Res 2003;66:15-21
44. Brock RW, Dorman RB. Obesity, insulin resistance and hepatic perfusion. Microcirculation 2007;14:339-347
45. Vicent D, Ilany J, Kondo T, Naruse K, Fisher SJ, Kisanuki YY, Bursell S, Yanagisawa M, King GL, Kahn CR. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest 2003;111:1373-1380
46. Jiang ZY, Lin YW, Clemont A, Feener EP, Hein KD, Igarashi M, Yamauchi T, White MF, King GL. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 1999;104:447-457
47. Namdaran K, Bracy DP, Lacy DB, Johnson JL, Bupp JL, Wasserman DH. Gut and liver fat metabolism in depancreatized dogs: effects of exercise and acute insulin infusion. J Appl Physiol 1997;83:1339-1347
48. Borra R, Lautamäki R, Parkkola R, Komu M, Sijens PE, Hällsten K, Bergman J, Iozzo P, Nuutila P. Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitus. Metabolism 2008;57:1445-1451
49. Barzilai N, Rossetti L. Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin. J Biol Chem 1993;268:25019-25025
50. Bajaj M, Pratipanawatr T, Berria R, Pratipanawatr W, Kashyap S, Cusi K, Mandarino L, DeFronzo RA. Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes. Diabetes 2002;51:3043-3048
51. Duckworth WC, Kitabchi AE. Insulin metabolism and degradation. Endocr Rev 1981;2:210-233
52. Altunkaynak BZ, Ozbek E. Overweight and structural alterations of the liver in female rats fed a high-fat diet: a stereological and histological study. Turk J Gastroenterol 2009;20:93-103